Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial.
Parsons CM, Harvey N, Shepstone L, Kanis JA, Lenaghan E, Clarke S, Fordham R, Gittoes N, Harvey I, Holland R, Redmond NM, Howe A, Marshall T, Peters TJ, Torgerson D, O'Neill TW, McCloskey E, Cooper C; SCOOP Trial Group.
Parsons CM, et al. Among authors: cooper c.
Osteoporos Int. 2020 Jan;31(1):67-75. doi: 10.1007/s00198-019-05142-z. Epub 2019 Oct 12.
Osteoporos Int. 2020.
PMID: 31606826
Free PMC article.
Clinical Trial.